Comparison of next‑generation sequencing quality metrics and concordance in the detection of cancer‑specific molecular alterations between formalin‑fixed paraffin‑embedded and fresh‑frozen samples in comprehensive genomic profiling with the Illumina&reg; TruSight Oncology 500 assay

Loderer,Dušan; Hornáková,Andrea; Tobiášová,Katarína; Lešková,Katarína; Halašová,Erika; Danková,Zuzana; Biringer,Kamil; Kúdela,Erik; Rokos,Tomáš; Dzian,Anton; Miklušica,Juraj; Mikolajčík,Peter; Smolár,Marek; Plank,Lukáš; Grendár,Marián

doi:10.3892/etm.2025.12814

Comparison of next‑generation sequencing quality metrics and concordance in the detection of cancer‑specific molecular alterations between formalin‑fixed paraffin‑embedded and fresh‑frozen samples in comprehensive genomic profiling with the Illumina® TruSight Oncology 500 assay

Authors:
- Dušan Loderer
- Andrea Hornáková
- Katarína Tobiášová
- Katarína Lešková
- Erika Halašová
- Zuzana Danková
- Kamil Biringer
- Erik Kúdela
- Tomáš Rokos
- Anton Dzian
- Juraj Miklušica
- Peter Mikolajčík
- Marek Smolár
- Lukáš Plank
- Marián Grendár
View Affiliations

Affiliations: Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, 036 01 Martin, Slovakia, Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava and University Hospital in Martin, 036 01 Martin, Slovakia, Clinic of Obstetrics and Gynaecology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, 036 01 Martin, Slovakia, Department of Thoracic Surgery, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, 036 59 Martin, Slovakia, Clinic of General, Visceral and Transplant Surgery, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, 036 59 Martin, Slovakia
Published online on: February 4, 2025 https://doi.org/10.3892/etm.2025.12814
Article Number: 64
Copyright: © Loderer et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Next‑generation sequencing (NGS) technology is routinely employed to detect clinically significant variants in the field of precision medicine. Formalin‑fixed paraffin‑embedded (FFPE) tissues remain a widely used source of genetic material for diagnostic purposes due to their long‑term storage stability, which preserves the architecture of tumour tissues. However, the degradation of nucleic acids (NAs) that occurs during the fixation process can lead to unreliable results or hinder analysis. Considering the challenges posed by the quality and quantity of nucleic acids extracted from FFPE samples, the present study aimed to compare paired fresh‑frozen (FF) and FFPE samples. The present study also aimed to assess the concordance rate of quality control metrics of sequenced libraries and identify variants and biomarkers between FFPE and FF tissues. The Illumina® TruSight Oncology 500 assay (TSO 500; Illumina, Inc.) was used to conduct comprehensive genomic profiling of samples from patients with various cancer types. All identified alterations were annotated using the Pierian Dx Clinical Genomics Workspace version 6.20 (PierianDx CGW). A total of 138 DNA and 138 RNA analyses on 69 paired samples were performed. These results demonstrated the significant potential of FF tissue as a primary source of higher‑quality genetic material to detect small variants, microsatellite instabilities and the tumour mutational burden, using the TSO 500 assay compared with FFPE samples. This approach could effectively reduce the issues associated with poor‑quality NAs extracted from FFPE samples. Based on our findings of lower concordance in the detection of splice variants, fusions and copy number variants in paired samples, we recommend that future studies using the TSO 500 assay should focus directly on this issue.

View Figures

View References

1	Giacò L, Palluzzi F, Guido D, Nero C, Giacomini F, Duranti S, Bria E, Tortora G, Cenci T, Martini M, et al: A computational framework for comprehensive genomic profiling in solid cancers: The analytical performance of a high-throughput assay for small and copy number variants. Cancers (Basel). 14(6152)2022.PubMed/NCBI View Article : Google Scholar
2	Froyen G, Geerdens E, Berden S, Cruys B and Maes B: Diagnostic validation of a comprehensive targeted panel for broad mutational and biomarker analysis in solid tumors. Cancers (Basel). 14(2457)2022.PubMed/NCBI View Article : Google Scholar
3	Conroy JM, Pabla S, Glenn ST, Seager RJ, Van Roey E, Gao S, Burgher B, Andreas J, Giamo V, Mallon M, et al: A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors. PLoS One. 16(e0260089)2021.PubMed/NCBI View Article : Google Scholar
4	Ottestad AL, Huang M, Emdal EF, Mjelle R, Skarpeteig V and Dai HY: Assessment of two commercial comprehensive gene panels for personalized cancer treatment. J Pers Med. 13(42)2022.PubMed/NCBI View Article : Google Scholar
5	Pestinger V, Smith M, Sillo T, Findlay JM, Laes JF, Martin G, Middleton G, Taniere P and Beggs AD: Use of an integrated pan-cancer oncology enrichment next-generation sequencing assay to measure tumour mutational burden and detect clinically actionable variants. Mol Diagn Ther. 24(505)2020.PubMed/NCBI View Article : Google Scholar
6	Meireles SI, Cruz MV, de Godoy CD and de Testagrossa L: Performance of non-formalin fixed paraffin embedded samples in hybrid capture and amplicon next-generation sequencing panels. Diagn Cytopathol. 52:171–182. 2024.PubMed/NCBI View Article : Google Scholar
7	Betge J, Kerr G, Miersch T, Leible S, Erdmann G, Galata CL, Zhan T, Gaiser T, Post S, Ebert MP, et al: Amplicon sequencing of colorectal cancer: Variant calling in frozen and formalin-fixed samples. PLoS One. 10(e0127146)2015.PubMed/NCBI View Article : Google Scholar
8	Robbe P, Popitsch N, Knight SJL, Antoniou P, Becq J, He M, Kanapin A, Samsonova A, Vavoulis DV, Ross MT, et al: Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: Pilot study for the 100,000 Genomes Project. Genet Med. 20:1196–1205. 2018.PubMed/NCBI View Article : Google Scholar
9	De Paoli-Iseppi R, Johansson PA, Menzies AM, Dias KR, Pupo GM, Kakavand H, Wilmott JS, Mann GJ, Hayward NK, Dinger ME, et al: Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making. Pathology. 48:261–266. 2016.PubMed/NCBI View Article : Google Scholar
10	Kerick M, Isau M, Timmermann B, Sültmann H, Herwig R, Krobitsch S, Schaefer G, Verdorfer I, Bartsch G, Klocker H, et al: Targeted high throughput sequencing in clinical cancer settings: Formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics. 4(68)2011.PubMed/NCBI View Article : Google Scholar
11	Fielding DI, Dalley AJ, Singh M, Nandakumar L, Lakis V, Chittoory H, Fairbairn D, Patch AM, Kazakoff SH, Ferguson K, et al: Evaluating diff-quik cytology smears for large-panel mutation testing in lung cancer-predicting DNA content and success with low-malignant-cellularity samples. Cancer Cytopathol. 131:373–382. 2023.PubMed/NCBI View Article : Google Scholar
12	R Core Team (2021) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, 2021.
13	tabulizer: Bindings for Tabula PDF Table Extractor Library. R package version 0.2.2.
14	Ooms J: The jsonlite Package: A practical and consistent mapping between JSON data and R Objects 2014.
15	Iannone R and Roy O: DiagrammeR: Graph/Network Visualization. 2024.
16	Iannone R: DiagrammeRsvg: Export DiagrammeR Graphviz Graphs as SVG. 2016.
17	Ooms J and Brüggemann S: Render SVG images into PDF, PNG, (Encapsulated) PostScript, or Bitmap Arrays 2023.
18	Larsson J, Godfrey AJR, Gustafsson P, Eberly DH, Huber E and Privé F: Area-proportional euler and venn diagrams with ellipses, 2024.
19	Knaus BJ and Grünwald NJ: vcfr: A package to manipulate and visualize VCF format data in R. Mol Ecol Resour. 17:44–53. 2017.PubMed/NCBI View Article : Google Scholar
20	Local run manager trusight oncology comprehensive (EU) analysis module. 2022.
21	Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ, Reeser JW, Yu L and Roychowdhury S: Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 17(00073)2017.PubMed/NCBI View Article : Google Scholar
22	Baum JE, Zhang P, Hoda RS, Geraghty B, Rennert H, Narula N and Fernandes HD: Accuracy of next-generation sequencing for the identification of clinically relevant variants in cytology smears in lung adenocarcinoma. Cancer Cytopathol. 125:398–406. 2017.PubMed/NCBI View Article : Google Scholar
23	Faber E, Grosu H, Sabir S, Lucas FAS, Barkoh BA, Bassett RL, Luthra R, Stewart J and Roy-Chowdhuri S: Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy. J Clin Pathol. 75:612–619. 2022.PubMed/NCBI View Article : Google Scholar
24	Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, et al: Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers. Cancer Cytopathol. 129:374–382. 2021.PubMed/NCBI View Article : Google Scholar
25	Pepe F, Pisapia P, Gristina V, Rocco D, Micheli M, Micheli P, Iaccarino A, Tufano R, Gragnano G, Russo G, et al: Tumor mutational burden on cytological samples: A pilot study. Cancer Cytopathol. 129:460–467. 2021.PubMed/NCBI View Article : Google Scholar
26	Sanghvi RV, Buhay CJ, Powell BC, Tsai EA, Dorschner MO, Hong CS, Lebo MS, Sasson A, Hanna DS, McGee S, et al: Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers. Genet Med. 20:855–866. 2018.PubMed/NCBI View Article : Google Scholar
27	Wang Q, Shashikant CS, Jensen M, Altman NS and Girirajan S: Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity. Sci Rep. 7(885)2017.PubMed/NCBI View Article : Google Scholar
28	Chou D, Chen X, Purdy A, Teng L, Luo B, Zhao C, Ball L, Castaneda A, Clark K, Crain B, et al: Abstract 3732: Analytical performance of TruSight^® Tumor 170 on small nucleotide variations and gene amplifications using DNA from formalin-fixed, paraffin-embedded (FFPE) solid tumor samples. Cancer Res. 2017.